Wide-awake Local Anesthesia and no Tourniquet (WALANT) in Plastic Surgery

May 7, 2024 updated by: Konstantinos Seretis, University Hospital, Ioannina

Wide-awake Local Anesthesia and no Tourniquet (WALANT) in Plastic Surgery: Indications, Clinical Applications and Outcomes

Wide-awake local anesthesia no tourniquet (WALANT) was proposed and performed in hand operations.

Aim of this study is to present the use of WALANT in operations performed on the upper and lower limbs, evaluate its efficacy in terms of feasibility, total operation time, total operating room time, bleeding, patient discomfort and satisfaction and control for potential drawbacks. The hypothesis is that WALANT is a viable option in common operations performed by plastic surgeons on the upper and lower limbs.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Wide-awake local anesthesia no tourniquet (WALANT) was proposed and performed in hand operations. Little has been studied, regarding its indications and efficacy in general plastic surgery operations.

Aim of this study is to present the use of WALANT in operations performed on the upper and lower limbs, evaluate its efficacy in terms of feasibility, total operation time, total operating room time, bleeding, patient discomfort and satisfaction and control for potential drawbacks. The hypothesis is that WALANT is a viable option in common operations performed by plastic surgeons on the upper and lower limbs.

A prospective study will be conducted comparing the use of WALANT in operations performed on the upper and lower limbs to the traditional use of tourniquet with general or regional anesthesia.

Study Type

Observational

Enrollment (Actual)

90

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Ioannina, Greece
        • Plastic Surgery Department

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years and older (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

patients who undergo general plastic surgery operations in the upper or lower limb

Description

Inclusion Criteria:

  • upper or lower limb operation
  • indication for flap or skin grafting
  • operated by the principal investigator

Exclusion Criteria:

  • other concomitant operations performed
  • known allergy to any of the ingredients of local anesthesia mixture

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Control
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
WALANT group
WALANT was used exclusively as anesthesia method for the operation
WALANT as anesthesia method for upper and lower limb palstic surgery operations
control
tourniquet with regional or general anesthesia was used for the operation
WALANT as anesthesia method for upper and lower limb palstic surgery operations

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
total operation time
Time Frame: through operation completion
the difference between skin incision and skin closure in minutes
through operation completion
operation theatre time
Time Frame: through operation completion with exit from the operation theatre
the difference between entry and exit of the patient from the operation theatre in minutes
through operation completion with exit from the operation theatre
Patient satisfaction
Time Frame: at 8 weeks
estimated by a 10-point visual analogue scale (1-10, 10 is the best outcome)
at 8 weeks
feasibility of the WALANT method
Time Frame: through operation completion
percentage of cases, which could not be completed under WALANT with conversion to the traditional method of anesthesia
through operation completion

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
complications
Time Frame: at 8 weeks
number and type of complications in each group
at 8 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2019

Primary Completion (Actual)

October 10, 2022

Study Completion (Actual)

May 5, 2023

Study Registration Dates

First Submitted

July 13, 2021

First Submitted That Met QC Criteria

July 27, 2021

First Posted (Actual)

August 5, 2021

Study Record Updates

Last Update Posted (Actual)

May 8, 2024

Last Update Submitted That Met QC Criteria

May 7, 2024

Last Verified

May 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 11335

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anesthesia, Local

Clinical Trials on WALANT

Subscribe